A Comprehensive Assessment of Adverse Events and Overall Safety Profile in HIV Positive Patients Treated with Dolutegravir as Compared to Other Integrase Strand Transfer Inhibitors or Darunavir (207832) First published 10/01/2018 Last updated 02/07/2024 EU PAS number:EUPAS22231 Study Finalised